Donors


DND
i is pleased to thank the various donors who are committed to the mission and vision of DND
i, and without whom, DND
i would not have been able to achieve its initial successes.
THANKS TO OUR DONORS
DND
i would like to thank the following donors for their support of DND
i’s activities since July 2003:
PUBLIC INSTITUTIONAL DONORS
Department for International Development (DFID) / UNITED KINGDOM• Grant period: 2006-2013
• Support to DND
i initiative
• Total amount: GBP 27,9 million
•
www.dfid.gov.uk• Link to
press release
Dutch Ministry of Foreign Affairs (DGIS) / THE NETHERLANDS • Grant period: 2011-2014
• Support to DND
i portfolio
• Total amount: EUR 14 million
•
www.minbuza.nl/en/ministry • Grant period: 2007-2010
• Support to DND
i malaria project (FACT)
• Total amount: EUR 2,9 million
•
www.minbuza.nl/en/ministry European and Developing Countries Clinical Trials Partnership (EDCTP) / EUROPE• Grant period: 2010-2012
• Support to clinical studies for the "Assessment of the fixed-dose combination of Artesunate Mefloquine (ASMQ) as an alternative antimalarial treatment for children in Africa”
• Total amount: EUR 381,000
•
www.edctp.org European Union - Framework Programme 5 and 6• Grant period: 2002-2006 / 2006-2009
• Support to DND
i malaria project (FACT) and Human African Trypanosomiasis Platform
• Total amount: EUR 241,300 / EUR 340,000
•
cordis.europa.eu/inco/home_en.html ec.europa.eu/research/iscp/index.cfm European Union - Framework Programme 7• Grant period: 2009-2011
• Support to LEISHDNAVAX - Development of a DNA vaccine for visceral leishmaniasis
• Total amount: EUR 253,800
•
cordis.europa.eu/inco/home_en.html ec.europa.eu/research/iscp/index.cfm French Development Agency (AFD) / FRANCE • Grant period: 2006-2010
• Support to DND
i malaria project (FACT)
• Total amount : EUR 2 million
•
www.afd.fr• Link to initial
press releaseGlobal Fund To fight AIDS, Tuberculosis and Malaria / INTERNATIONAL• Grant period: 2010-2012
• Support to "Baseline and Endpoint Surveys Work for the Independant Evaluation of Phase 1 of the Affordable Medicines Facility - malaria (AMFm)" in Ghana
• Total amount: EUR 518,200
•
www.theglobalfund.org/en/GTZ on behalf of the Government of the Federal Republic of Germany / GERMANY• Grant period: 2008–2009
• Support to specific discovery, preclinical/clinical projects (Chagas lead optimisation, Fexinidazole)
• Total amount: EUR 1 million
•
www.gtz.de/en/Federal Ministry of Education and Research (BMBF) / GERMANY• Grant period: 2011-2014
• Support to DND
i initiative
• Total amount: EUR 8 million
•
www.bmbf.de/en/index.phpMinistry of Foreign and European Affairs (MAEE) / FRANCE • Grant period: 2007-2009
• Support to specific projects for Human African Trypanosomiasis (Fexinidazole, NECT) and visceral leishmaniasis (Buparvaquone, Paromomycin, AmBisome) and capacity building (LEAP, HAT platform)
• Total amount: EUR 5,9 million
•
www.diplomatie.gouv.fr/fr/• Grant period: 2009-2011
• Support to specific discovery and preclinical projects (IPK screening, HAT lead optimisation, Oxaborole for HAT)
• Total amount: EUR 1,3 million
•
www.diplomatie.gouv.fr/fr/National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) / UNITED STATES OF AMERICA• Grant period: 2007-2012
• Support to Amphotericin B Polymer project
• Total amount USD 2,4 million
•
www.nih.gov/ http://www3.niaid.nih.gov/• Link to
press release• Grant period: 2007-2013
• Support to K777 for Chagas Project
• Total amount USD 1,2 million
Region of Tuscany / ITALY• Grant period: 2006-2007
• Support to Paromomycin project
• Total amount: EUR 200,000
•
www.regione.toscana.it/prehome_1024.htm Republic and Canton of Geneva, Institution Department, International Solidarity / SWITZERLAND • Grant period: 2010-2012
• Support to NECT-Field project
• Total amount: CHF 600,000
• Grant period: 2004-2009
• Support to paromomicyn project
• Total amount: CHF 1 million
• www.ge.ch
Spanish Agency for International Development Cooperation (AECID) / SPAIN• Grant period: 2007-2012
• Support to DND
i initiative
• Total amount: EUR 11 million
•
www.aecid.es/es/Swiss Agency for Development and Cooperation (SDC) / SWITZERLAND• Grant period: 2010-2012
• Support to DND
i initiative
• Total amount: CHF 4 million
•
www.deza.ch/en/Home PRIVATE DONORSBill & Melinda Gates Foundation / UNITED STATES OF AMERICA • Grant period: 2007-2012
• Total amount: USD 27,2 million
• Support to HAT lead optimization and VL lead optimisation project
•
www.gatesfoundation.org/default.htm • Link to
press release• Grant period: 2009-2014
• Total amount: USD 15 million
• Support to the clinical development of fexinidazole for the treatment of HAT
•
www.gatesfoundation.org/default.htm • Link to
press release• Grant period: 2011-2014
• Total amount: USD 5,8 million
• Support to the development of flubendazole as a macrofilaricidal drug candidate for the treatment of onchocerciasis and
Loa loa coinfections
•
www.gatesfoundation.org/default.htm • Link to
press release• Grant period: 2011-2013
• Total amount: USD 2 million
• Support to NTDs screening
•
www.gatesfoundation.org/default.htm • Grant period: 2011-2015
• Total amount: USD 9 million
• Support to adoption and implementation of VL combination treatments in Asia
•
www.gatesfoundation.org/default.htm • Link to
press releaseMédecins Sans Frontières (Doctors without Borders) / INTERNATIONAL• Grant period:2003-2014
• Total amount: EUR 42,5 million
• Support to DND
i initiative
•
www.msf.org• Link to
press releaseMédecins Sans Frontières (Doctors without Borders) / ITALY• Grant period:2010-2011
• Total amount: EUR 600,000
• Support to the development and registration of paediatric benznidazole
•
www.medicisenzafrontiere.it/• Link to
press release• Grant period:2009
• Total amount: EUR 100,000
• Support to DND
i malaria project (FACT) - Liberia study
•
www.medicisenzafrontiere.it/• Link to
press releaseMédecins Sans Frontières (Doctors without Borders) / NORWAY
• Grant period:2011
• Total amount: EUR 350,000
• Support to R&D for HIV paediatric
•
www.leger-uten-grenser.no
• Grant period:2010
• Total amount: EUR 165,000
• Support to R&D opportunities for helmints and HIV paediatric
•
www.leger-uten-grenser.no Médecins Sans Frontières (Doctors without Borders) / BRAZIL
• Grant period:2011-2012
• Total amount: R$ 1 million
• Support to the development and registration of paediatric benznidazole
•
www.msf.org.br
PRIVATE FOUNDATIONS AND PRIVATE INDIVIDUAL DONORS
Fondation André & Cyprien / SWITZERLAND
Medicor Foundation / LIECHTENSTEIN
The Sasakawa Peace Foundation / JAPAN
The Starr International Foundation / SWITZERLANDand others that would like to remain anonymous.
top of the page